Company: ARAI
Filing Date: 2025-04-18
Form Type: S-1/A
Source: 0001641172-25-005394
Chunk: 185

Company: Arrive AI Inc.
Filing Date: 2025-04-18
Form: S-1/A
Chunk 185
---
 Share Options |     | Weighted       
 Average        
 Exercise Price |      |     | Weighted Average Remaining Contractual Life-Years |     |     | Aggregate Intrinsic Value |           |
|:--------------|:----|:---------------|-----:|:----|:--------------------------------------------------|----:|:----|:--------------------------|----------:|
| 169,829       |     | $              | 0.80 |     |                                                   | 8.9 |     | $                         | 2,056,845 |

The following is a summary of the changes in nonvested share options (on a post-reverse split basis) as of December 31, 2024:

|                                             |     | Share Options |         |   |     | Weighted              
 Average               
 Grant Date Fair Value |       |
|:--------------------------------------------|:----|:--------------|--------:|:--|:----|:----------------------|------:|
| NONVESTED SHARE OPTIONS - DECEMBER 31, 2023 |     |               | 494,105 |   |     | $                     | 10.80 |
| Granted                                     |     |               |  45,565 |   |     |                       | 11.80 |
| Vested                                      |     |               | (86,665 | ) |     |                       | 10.89 |
| Cancelled                                   |     |               |    (130 | ) |     |                       | 10.30 |
| NONVESTED SHARE OPTIONS - DECEMBER 31, 2024 |     |               | 452,875 |   |     | $                     | 10.89 |

There were 45,565 options (on a post-reverse split basis) granted during the year ended December 31, 2024 and each option had an average grant date fair value of $11.80 per share (as adjusted for the 1-for-4 reverse split). As of December 31, 2024, there was $4,930,679 unrecognized compensation expense related to nonvested stock options to be recognized over the remaining vesting period. Total compensation expense related to stock options during the year ended December 31, 2024 was $978,234. No options were exercised during the year ended December 31, 2024.

| 15. | RESEARCH                
 AND DEVELOPMENT CREDITS |

Under the Internal Revenue Service (IRS) Form 6765, the Company is